Misbah Tahir, Chief Financial Officer at IGM Biosciences, Inc. (IGMS), sold 6,084 shares at $20.00 ($119K) on 2022-12-19, disclosed to the SEC on 2022-12-20.
Open-market sale of $119k IGMS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.77 | 1,468 | $28K | 23.1% |
| 2 | $19.36 | 815 | $16K | 13.2% |
| 3 | $20.00 | 3,801 | $76K | 63.7% |
| Total | $19.62 avg | 6,084 | $119K | 100% |
| Filing → |
| IGMS | SELL | 2025-03-18 | $9K | — | Filing → |
| IGMS | SELL | 2024-12-18 | $13K | — | Filing → |
| IGMS | SELL | 2024-09-17 | $17K | — | Filing → |